4328-04-5

Basic information

• Product Name: TETRAKIS(2-HYDROXYETHYL)AMMONIUM BROMIDE
• Synonyms: TETRAKIS(2-HYDROXYETHYL)AMMONIUM BROMIDE;2-hydroxy-n,n,n-tris(2-hydroxyethyl)-ethanaminiubromide;Tetrakis(2-hydroxyethyl)ammoniumbromide,99%
• CAS NO: 4328-04-5
• Molecular Formula: Br*C₈H₂₀NO₄
• Molecular Weight: 274.15
• EINECS: 224-362-6
• Mol File: 4328-04-5.mol
• Article Data: 5

Chemical Properties

• Melting Point: 191 °C
• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: White or almost white/Crystalline Powder
• Density: 1.5267 (rough estimate)
• Refractive Index: 1.6500 (estimate)
• CAS DataBase Reference: TETRAKIS(2-HYDROXYETHYL)AMMONIUM BROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: TETRAKIS(2-HYDROXYETHYL)AMMONIUM BROMIDE(4328-04-5)
• EPA Substance Registry System: TETRAKIS(2-HYDROXYETHYL)AMMONIUM BROMIDE(4328-04-5)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 4328-04-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H20NO4.BrH/c10-5-1-9(2-6-11,3-7-12)4-8-13;/h10-13H,1-8H2;1H/q+1;/p-1

Upstream product

• 121-44-8 triethylamine 
• 540-51-2 2-bromoethanol 
• 102-71-6 triethanolamine 
• 75-21-8 oxirane 
• 25114-70-9 triethanolammonium bromide 

Downstream Products

• 631-41-4 tetrakis(2-hydroxyethyl)ammonium hydroxide 

Relevant articles and documents

New cardiolipin analogs synthesized by phospholipase D-catalyzed transphosphatidylation

Cardiolipin (CL) and related diphosphatidyl lipids are hardly accessible because of the complexity of their chemical synthesis. In the present paper, the transphosphatidylation reaction catalyzed by phospholipase D (PLD) from Streptomyces sp. has been proven as an alternative enzyme-assisted strategy for the synthesis of new CL analogs. The formation of this type of compounds from phosphatidylcholine was compared for a series of N- and C2-substituted ethanolamine derivatives as well as non-charged alcohols such as glycerol and ethylene glycol. The rapid exchange of the choline head group by ethanolamine derivatives having a low molecular volume (diethanolamine and serinol) gave rise to an efficient production of the corresponding CL analogs. In contrast, the yields were comparably low in the reaction with bulky nitrogenous acceptor alcohols (triethanolamine, tris(hydroxymethyl)aminomethane, tetrakis(hydroxyethyl)ammonium) or the non-charged alcohols. Therefore, a strong dependence of the conversion of the monophosphatidyl to the diphosphatidyl compound on steric parameters and the head group charge was concluded. The enzyme-assisted strategy was used for the preparation of purified diphosphatidyldiethanolamine and diphosphatidylserinol.

ORGANIC ELECTROLYTE COMPOUNDS FOR REDOX-FLOW BATTERIES

The present invention relates to redox electrolyte compounds. The present invention further relates to a redox-flow battery wherein one of the catholyte and the anolyte, or both, has the redox electrolyte compound of the invention. The present invention further relates to the method of controlling the redox-flow battery and its use for energy storage.

4-HYDROXY BENZOATE DERIVATIVES FOR USE IN THE TREATMENT OF INFECTION, INFLAMMATION OR PAIN

The invention provides a compound of the general formula (I) for use in the topical treatment of infection, inflammation and/or pain: wherein R1 independently represents a methylene group, an ethylene group or a straight or branched chain C3 to C6 alkylene group; R2 independently represents a hydrogen atom, a methyl group, an ethyl group or a straight or branched chain C3 to C20 alkyl group; x represents 0 or an integer from 1 to 4 and y represents 0 or an integer from 1 to 4, wherein the sum of x and y is 4; and Z represents a hydrogen atom or (HOR1)yR2XN⊕; compositions comprising the compound; use of the compound in the manufacture of a medicament; and methods of medical treatment comprising the topical application of the compound.